These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 33652659)

  • 1. Outcome of Stage IV Completely Necrotic Wilms Tumour and Local Stage III Treated According to the SIOP 2001 Protocol.
    Dávila Fajardo R; Furtwängler R; van Grotel M; van Tinteren H; Pasqualini C; Pritchard-Jones K; Al-Saadi R; de Camargo B; Ramírez Villar GL; Graf N; Muracciole X; Melchior P; Saunders D; Rübe C; van den Heuvel-Eibrink MM; Janssens GO; Verschuur AC
    Cancers (Basel); 2021 Feb; 13(5):. PubMed ID: 33652659
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Omission of adjuvant chemotherapy in patients with completely necrotic Wilms tumor stage I and radiotherapy in stage III: The 30-year SIOP-RTSG experience.
    Vujanić GM; Graf N; D'Hooghe E; Pritchard-Jones K; Bergeron C; Tinteren HV; Furtwängler R;
    Pediatr Blood Cancer; 2024 Mar; 71(3):e30852. PubMed ID: 38185745
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of boost irradiation in patients with intermediate-risk stage III Wilms tumour with positive lymph nodes only: Results from the SIOP-WT-2001 Registry.
    Dávila Fajardo R; Oldenburger E; Rübe C; López-Yurda M; Pritchard-Jones K; Bergeron C; Graf N; van Grotel M; van Tinteren H; Saunders D; van den Heuvel-Eibrink MM; Janssens GO; Oldenburger F
    Pediatr Blood Cancer; 2018 Aug; 65(8):e27085. PubMed ID: 29693799
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Outcome of localised blastemal-type Wilms tumour patients treated according to intensified treatment in the SIOP WT 2001 protocol, a report of the SIOP Renal Tumour Study Group (SIOP-RTSG).
    van den Heuvel-Eibrink MM; van Tinteren H; Bergeron C; Coulomb-L'Hermine A; de Camargo B; Leuschner I; Sandstedt B; Acha T; Godzinski J; Oldenburger F; Gooskens SL; de Kraker J; Vujanic GM; Pritchard-Jones K; Graf N
    Eur J Cancer; 2015 Mar; 51(4):498-506. PubMed ID: 25592561
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Is radiotherapy required in first-line treatment of stage I diffuse anaplastic Wilms tumor? A report of SIOP-RTSG, AIEOP, JWiTS, and UKCCSG.
    Fajardo RD; van den Heuvel-Eibrink MM; van Tinteren H; Spreafico F; Acha T; Bergeron C; de Camargo B; Oldenburger F; Rübe C; Oue T; Vokuhl C; de Krijger RR; Vujanic G; Sebire N; Coulomb-L'Hermine A; Collini P; Gandola L; Pritchard-Jones K; Graf N; Janssens GO; van Grotel M
    Pediatr Blood Cancer; 2020 Feb; 67(2):e28039. PubMed ID: 31625685
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical outcomes of children with Wilms tumor treated on a SIOP WT 2001 protocol in a tertiary care hospital in south India.
    John R; Kurian JJ; Sen S; Gupta MK; Jehangir S; Mathew LG; Mathai J
    J Pediatr Urol; 2018 Dec; 14(6):547.e1-547.e7. PubMed ID: 30017606
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Outcome of SIOP patients with low- or intermediate-risk Wilms tumour relapsing after initial vincristine and actinomycin-D therapy only - the SIOP 93-01 and 2001 protocols.
    Groenendijk A; van Tinteren H; Jiang Y; de Krijger RR; Vujanic GM; Godzinski J; Rübe C; Schenk JP; Morosi C; Pritchard-Jones K; Al-Saadi R; Vaidya SJ; Verschuur AC; Ramírez-Villar GL; Graf N; de Camargo B; Drost J; Perotti D; van den Heuvel-Eibrink MM; Brok J; Spreafico F; Mavinkurve-Groothuis AMC
    Eur J Cancer; 2022 Mar; 163():88-97. PubMed ID: 35042071
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Characteristics and outcome of stage II and III non-anaplastic Wilms' tumour treated according to the SIOP trial and study 93-01.
    Graf N; van Tinteren H; Bergeron C; Pein F; van den Heuvel-Eibrink MM; Sandstedt B; Schenk JP; Godzinski J; Oldenburger F; Furtwängler R; de Kraker J
    Eur J Cancer; 2012 Nov; 48(17):3240-8. PubMed ID: 22795263
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Preoperative Wilms tumor rupture in children.
    Zhang Y; Song HC; Yang YF; Sun N; Zhang WP; Huang CR
    Int Urol Nephrol; 2021 Apr; 53(4):619-625. PubMed ID: 33245535
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Nephroblastoma -  30-years period of its treatment in the University Hospital Motol, Prague].
    Mališ J; Švojgr K; Pýcha K; Jeřábková V; Cyprová S; Churáčková M; Šmelhaus V; Radvanský J; Zítková M; Kodet R; Kodetová D; Malinová B; Koutecký J; Šnajdauf J; Starý J
    Klin Onkol; 2013; 26(5):336-42. PubMed ID: 24107156
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Preoperative chemotherapy and local stage III in nephroblastoma.
    Graf N; Furtwängler R
    Transl Pediatr; 2014 Jan; 3(1):4-11. PubMed ID: 26835317
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Outcomes of patients with Wilms' tumour stage III due to positive resection margins only: An analysis of patients treated on the SIOP-WT-2001 protocol in the UK-CCLG and GPOH studies.
    Vujanić GM; Graf N; D'Hooghe E; Chowdhury T; Vokuhl C; Al-Saadi R; Pritchard-Jones K; Melchior P; Furtwängler R
    Int J Cancer; 2023 Apr; 152(8):1640-1647. PubMed ID: 36444500
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Outcome of patients with stage IV high-risk Wilms tumour treated according to the SIOP2001 protocol: A report of the SIOP Renal Tumour Study Group.
    Pasqualini C; Furtwängler R; van Tinteren H; Teixeira RAP; Acha T; Howell L; Vujanic G; Godzinski J; Melchior P; Smets AM; Coulomb-L'Hermine A; Brisse H; Pritchard-Jones K; Bergeron C; de Camargo B; van den Heuvel-Eibrink MM; Graf N; Verschuur AC
    Eur J Cancer; 2020 Mar; 128():38-46. PubMed ID: 32109849
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical characteristics and outcomes of children with WAGR syndrome and Wilms tumor and/or nephroblastomatosis: The 30-year SIOP-RTSG experience.
    Hol JA; Jongmans MCJ; Sudour-Bonnange H; Ramírez-Villar GL; Chowdhury T; Rechnitzer C; Pal N; Schleiermacher G; Karow A; Kuiper RP; de Camargo B; Avcin S; Redzic D; Wachtel A; Segers H; Vujanic GM; van Tinteren H; Bergeron C; Pritchard-Jones K; Graf N; van den Heuvel-Eibrink MM;
    Cancer; 2021 Feb; 127(4):628-638. PubMed ID: 33146894
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Outcome of patients with stage III or inoperable WT treated on the second United Kingdom WT protocol (UKWT2); a United Kingdom Children's Cancer Study Group (UKCCSG) study.
    Grundy RG; Hutton C; Middleton H; Imeson J; Pritchard J; Kelsey A; Marsden HB; Vujanic GM; Taylor RE;
    Pediatr Blood Cancer; 2004 Apr; 42(4):311-9. PubMed ID: 14966826
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The contribution of chest CT-scan at diagnosis in children with unilateral Wilms' tumour. Results of the SIOP 2001 study.
    Smets AM; van Tinteren H; Bergeron C; De Camargo B; Graf N; Pritchard-Jones K; de Kraker J
    Eur J Cancer; 2012 May; 48(7):1060-5. PubMed ID: 21703848
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Optimal neoadjuvant chemotherapy duration in Wilms tumour with intravascular thrombus: A literature review and evidence from SIOP WT 2001 trial.
    Morris L; Squire R; Sznajder B; van Tinteren H; Godzinski J; Powis M
    Pediatr Blood Cancer; 2019 Nov; 66(11):e27930. PubMed ID: 31339231
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Minichromosome maintenance 2 (MCM2) is a new prognostic proliferative marker in Wilms tumour.
    Taran K; Sitkiewicz A; Andrzejewska E; Kobos J
    Pol J Pathol; 2011; 62(2):84-8. PubMed ID: 21866463
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prognostic significance of histopathological response to preoperative chemotherapy in unilateral Wilms' tumor: An analysis of 899 patients treated on the SIOP WT 2001 protocol in the UK-CCLG and GPOH studies.
    Vujanić GM; D'Hooghe E; Graf N; Vokuhl C; Al-Saadi R; Chowdhury T; Pritchard-Jones K; Furtwängler R
    Int J Cancer; 2021 Sep; 149(6):1332-1340. PubMed ID: 34109628
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Position paper: Rationale for the treatment of Wilms tumour in the UMBRELLA SIOP-RTSG 2016 protocol.
    van den Heuvel-Eibrink MM; Hol JA; Pritchard-Jones K; van Tinteren H; Furtwängler R; Verschuur AC; Vujanic GM; Leuschner I; Brok J; Rübe C; Smets AM; Janssens GO; Godzinski J; Ramírez-Villar GL; de Camargo B; Segers H; Collini P; Gessler M; Bergeron C; Spreafico F; Graf N;
    Nat Rev Urol; 2017 Dec; 14(12):743-752. PubMed ID: 29089605
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.